cancer doctors

Pancreas Cancer Prognosis

Question: what is the prognosis of cancer pancreas after chemo and radiotherapy? the patient is74 y. coplicated by diabetes and tumour m. ca19.9 after tretment lowered from 35000 to 1200

Answer: Generally speaking not good unfortunately. Chemotherapy response may be better in patients who are BRCA2 gene carriers. Some centers have protocols that allow neo-adjuvant chemo- (& radiation-) therapy before down-staging locally unresectable cancers in order to later allow surgical resection. The use of radiation in locally unresctable cancers is also the subject of some controversy. Best people to discuss these questions with are the medical and radiation oncologists involved.


Pancreas Cancer Prognosis News

Pancreatic Cancer Overuns Ben Gazarra

dailyRx
While pancreatic cancer is relatively rare, the prognosis after diagnosis is not good. Most people aren't alive two years after learning they have it. The American Cancer Society estimates that each year in the United States, 44000 new cases of ...
 

Targovax Secures NOK 13 Million Series A Funding for TGO1 Pancreatic Cancer ...

MarketWatch (press release)
This is promising within a disease with a very bad prognosis. Pancreatic cancer is a disease affecting 112 000 patients each year in EU and USA, and approximately 690 persons each year in Norway. Approx 15-20% of these are discovered at an early stage ...
 

ABC7Chicago.com

2012 GASTROINSTESTINAL CANCERS SYMPOSIUM REVEALS NEW ADVANCES AIMED AT ...
FierceBiotech
 

Daily Mail

New technology to tackle treatment-resistant cancers
PhysOrg.com
 

Lessons from Cancer: The appalling facts of lung cancer

St. James Plaindealer
The day that each of us was diagnosed with lung cancer, 669 other people in the United States were also diagnosed, and on that same day, 435 people died from it. Today, the lung cancer survival rate of only 15 percent remains mostly unchanged since the ...
 

New research into treatment, prognosis and early detection of GI cancers

News-Medical.net
When combined with another tumor marker commonly used to monitor disease progression, the new test found 85 percent of patients with pancreatic cancer. 3) Study Finds Prognostic Factors for Rare Neuroendocrine Tumors, Suggests Everolimus May Be More ...
 

'Fluid biopsy' technique could transform cancer treatment

Nursing Times
The technique has been successfully tested in patients with breast, prostate and pancreatic cancer, and it is also hoped it will help scientists work out the mysteries of metastasis. Hailing the findings, published in the Institute of Physics journal ...
 

Mayor's cancer prognosis good; hopes to get back on job

Willcox Range News
Due to the excellent care of Dr. Hamilton in the emergency room and his 'don't give up attitude' and the follow-up by staff at NCCH, it was determined that I have cancer in my sinus, liver, pancreas, kidney, and lungs," he said in a letter to the Range ...
 

Refining the Use of Everolimus for Neuroendocrine Tumors

Medscape
January 17, 2012 (San Francisco, California) ? In patients with advanced neuroendocrine tumors that originate outside the pancreas, a new set of prognostic factors can help identify which patients are at greatest risk for progression and are more ...
 

Minimally invasive procedures allow Pulmonologist to diagnose/stage chest ...

Richmond County Daily Journal
The number-one cause of cancer-related death, lung cancer kills more people than breast, prostate, colon and pancreatic cancers combined. If diagnosed at Stage I, the lung cancer survival rate at 10 years is 88 percent. If diagnosed at Stage III or IV, ...
 

Types of Cancer


Adrenal Cancer Anal Cancer Brain Cancer Colorectal Cancer Endometrial Cancer Esophageal Cancer
Esophageal Cancer Laryngeal Cancer Oral Cancer Penile Cancer Prostatic Cancer Stomach Cancer
Thyroid Cancer Bladder Cancer Bone Cancer Cervix Cancer Heart Cancer Kidney Cancer
Melanoma Cancer Pancreas Cancer Asbestos Cancer